As of 13:38 on November 20, 2024, the SSE Science and Technology Innovation Board 100 Index (000698) rose 1.87% strongly, the constituent stocks Huaxing Yuanchuang (688001) rose 14.87%, Allist (688578) rose 13.10%, Zhixiang Jintai (688443) rose 11.90%, Rongchang Biotechnology (688331), Guodun Quantum (688027) and other stocks followed suit. The STAR 100 ETF Fund (588220) rose 1.93%.

In terms of share, the share of the Science and Technology Innovation 100 ETF fund has increased by 1.645 billion in the past six months, achieving significant growth.

The data shows that leveraged funds continue to be deployed. The latest financing purchase amount of the Kechuang 100 ETF fund reached 43.3972 million yuan, and the latest financing balance reached 252 million yuan.

The CITIC Securities research report pointed out that looking forward to 2025, the main line of investment in the technology industry will continue to revolve around AI. With the continuous progress of large model capabilities in multimodality and logical reasoning, AI is expected to be deeply integrated with the digital and intelligent transformation of thousands of industries, from computing infrastructure to terminal applications, and continue to drive investment in the technology industry.

According to the data, as of October 31, 2024, the top 10 weighted stocks of the SSE Science and Technology Innovation Board 100 Index (000698) are BeiGene (688235), Ruichuang Micro-Nano (688002), Smartway (688213), Guodun Quantum (688027), Hengxuan Technology (688608), Xinyuan Micro (688037), Anji Technology (688019), Tebao Biotechnology (688278), Aibo Medical (688050), NOVOSENSE (688052), the top ten weighted stocks accounted for 23.14%.

STAR 100 ETF Fund (588220), OTC Connect (Class A: 019861; Category C: 019862).